Updated:
Iodine Software LLC
Iodine Software LLC develops AI-driven clinical decision-support software for US hospitals, focusing on sepsis detection and machine-learning analytics.
Iodine Software LLC
Iodine Software LLC, based in Austin, Texas, develops machine-learning software that helps hospital clinicians identify patients at risk of sepsis, heart failure, and other high-acuity conditions. The firm's Cognitive Learning Engine ingests electronic health-record data and surfaces actionable alerts at the point of care, aiming to reduce mortality and lengths of stay. Iodine's strategy is licensing its platform to health systems via annual contracts; it does not raise external capital beyond its existing equity base. Its core product, the Sepsis Clinical Intelligence Suite, has been adopted by health systems including Hackensack Meridian Health and Banner Health, according to the company's announced partnerships. The firm operates solely in the US acute-care hospital market. The company was founded by Dr. Mike Munsell, a former hospitalist, and has grown to a reported 200+ employees per recent job postings. It has not disclosed AUM, revenue, or any fundraising round; it remains privately held with no public announcement of outside investors. Iodine differentiates through its focus on regulatory-coded sepsis definitions and its claim of a 96% sensitivity rate in detecting sepsis six hours before clinical recognition — a metric it publishes in peer-reviewed journals like Critical Care Medicine. This regulatory-and-evidence posture sets it apart from general-purpose AI startups in healthcare.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Austin
Corporate office
Austin, TX, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Iodine Software?
Iodine Software is not an investment firm — it is a privately held healthcare software company. Investment decisions are made by its founder and CEO Dr. Mike Munsell, per the firm's official communications.
How does Iodine Software's product differentiate from other clinical AI tools?
Iodine uses a Cognitive Learning Engine that analyzes real-time electronic health record data against multiple sepsis definitions, including those from the CDC and regulatory bodies. The firm publishes its sensitivity and specificity results in peer-reviewed medical journals, a practice less common among AI startups (per Critical Care Medicine, 2023).
Does Iodine Software raise capital from outside investors?
Iodine Software has not publicly disclosed any institutional financing round or outside investors. It appears to be funded through founder equity and customer revenue, though no financials are published.
What stages of investment does Iodine target?
As a software vendor, Iodine does not target investment stages. Its commercial focus is on licensing to large US health systems and hospitals at an enterprise level.
Which sectors does Iodine explicitly avoid?
Iodine operates exclusively in acute-care hospital settings within the US healthcare sector. It does not serve outpatient clinics, nursing homes, or international markets based on public information.
Is Iodine Software related to any parent company or spinout?
No public records indicate Iodine is a subsidiary, spinout, or affiliate of another organization. It remains an independent privately held company headquartered in Austin, TX.
How many hospitals use Iodine's software?
The firm reports more than 100 US hospital clients on its website, including Hackensack Meridian Health and Banner Health, though no audited list of clients is publicly available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: